
Canopy Publishes Research at 2023 American Society of Clinical Oncology Meeting
21-Month Study Demonstrates the Impact of ePROs in Identifying Patients at Risk of Early Treatment Discontinuation New York, New York - Canopy, the first Intelligent Care Platform for oncology, today announced results from a 21-month, real-world study demonstrating that electronic patient-reported outcomes (ePROs) can help identify common side effects in lung cancer patients receiving immunotherapy, both as monotherapy and in combination with chemotherapy. The Identification of key symptomatic differences in patients with shorter duration of therapy could suggest that aggressive early management can extend time on therapy, leading to improved outcomes.
Read more








